Overview

Parkinsonian Brain Repair Using Human Stem Cells

Status:
Unknown status

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

Implantation of Celavie human stem cells (OK99) is intended to address the underlying pathology of the disease by replacing damaged/destroyed cells of the brain, and/or stimulating the patient's brain to repair itself.

Phase:

Phase 1

Details

Lead Sponsor:

Celavie Bioscences, LLC

Collaborator:

Hospital Angeles del Pedregal